The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 22-28

  Uzar, Ertuǧrul ^a   Acar, Abdullah ^a   Evliyaoǧlu, Osman ^a   Firat, Uǧur ^a   Kamasak, Kaǧan ^a   Göçmez, Cüneyt ^a   Alp, Harun ^a   Tüfek, Adnan ^a   Taşdemir, Nebahat ^a   Ilhan, Atilla ^b  

^a DICLE UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Nebivolol; Oxidative stress; Prolidase; Zofenopril

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CASPASE 3; MALONALDEHYDE; NEBIVOLOL; NITRIC OXIDE; PROLINE DIPEPTIDASE; ZOFENOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOSIS ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY; COLORIMETRY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HYPOTENSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; TREATMENT RESPONSE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZOPYRANS; BRAIN ISCHEMIA; CAPTOPRIL; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ETHANOLAMINES; FEMALE; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 82555172350     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.08.011     Document Type: Article

References (53)

1. Alp R., Selek S., Alp S.I., Taskin A., Kocyigit A. Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 2010, 14:877-882.
2. Altunoluk B., Soylemez H., Oguz F., Turkmen E., Fadillioglu E. An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006, 36:326-332.
3. Amantea D., Nappi G., Bernardi G., Bagetta G., Corasaniti M.T. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009, 276:13-26.
4. Ambrosioni E. Defining the role of zofenopril in the management of hypertension and ischemic heart disorders. Am J Cardiovasc Drugs 2007, 7:17-24.
5. Borghi C., Ambrosioni E. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study. Am Heart J 2007, 153:7-14. Survival of Myocardial Infarction Long-term Evaluation Study Group.
6. Cacciatore F., Bruzzese G., Vitale D.F., Liguori A., de Nigris F., Fiorito C., et al. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur J Clin Pharmacol 2011, 10.1007/s00228-011-1029-0.
7. Cominacini L., Pasini A., Garbin U., Evangelista S., Crea A.E., Tagliacozzi D., et al. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am J Hypertens 2002, 15:891-895.
8. Cominacini L., Fratta, Pasini A., Garbin U., Nava C., Davoli A., et al. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol 2003, 42:1838-1844.
9. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990, 36:1440-1443.
10. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 2007, 7:1223-1233.
11. Eckerson H.W., Romson J., Wyte C., La Du B.N. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983, 35:214-227.
12. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37:277-285.
13. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38:1103-1111.
14. Evangelista S., Garbin U., Pasini A.F., Stranieri C., Boccioletti V., Cominacini L. Effect of dl-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. Pharmacol Res 2007, 55:303-309.
15. Flynn R.W., MacWalter R.S., Doney A.S. The cost of cerebral ischaemia. Neuropharmacology 2008, 55:250-256.
16. Frascarelli S., Ghelardoni S., Ronca-Testoni S., Zucchi R. Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion. J Cardiovasc Pharmacol 2004, 43:294-299.
17. Fridovich I. Superoxide dismutase. Adv Enzymol 1974, 41:35-97.
18. Gandhi C., Zalawadia R., Balaraman R. Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats. Ren Fail 2008, 30:921-930.
19. Garrido A.M., Griendling K.K. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009, 302:148-158.
20. Gschwend S., Haug M.B., Nierhaus M., Schulz A., Vetter R., Kossmehl P., et al. Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure. Life Sci 2009, 85:431-437.
21. Hu M.L., Louie S., Cross C.E., Motchnik P., Halliwell B. Antioxidant protection against hyochlorous acid in human plasma. J Lab Clin Med 1993, 121:257-262.
22. Ilhan A., Yilmaz H.R., Armutcu F., Gurel A., Akyol O. The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1153-1160.
23. Jung J.E., Kim G.S., Chen H., Maier C.M., Narasimhan P., Song Y.S., et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 2010, 41:172-179.
24. Kamp O., Metra M., Bugatti S., Bettari L., Dei Cas A., Petrini N., et al. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. Drugs 2010, 70:41-56.
25. Khan M., Elango C., Ansari M.A., Singh I., Singh A.K. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem 2007, 102:365-377.
26. Kilinc M., Gürsoy-Ozdemir Y., Gürer G., Erdener S.E., Erdemli E., Can A., et al. Lysosomal rupture, necroapoptotic interactions and potential crosstalk between cysteine proteases in neurons shortly after focal ischemia. Neurobiol Dis 2010, 40:293-302.
27. Koh P.O. Melatonin regulates nitric oxide synthase expression in ischemic brain injury. J Vet Med Sci 2008, 70:747-750.
28. Kuang X., Yao Y., Du J.R., Liu Y.X., Wang C.Y., Qian Z.M. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 2006, 1102:145-153.
29. Lapchak P.A. Effect of internal carotid artery reperfusion in combination with Tenecteplase on clinical scores and hemorrhage in a rabbit embolic stroke model. Brain Res 2009, 1294:211-217.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randal R.J. Protein measurement with the Folin phenol reagent. J Biochem Chem 1951, 19:265-275.
31. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:676-692.
32. Mak I.T., Freedman A.M., Dickens B.F., Weglicki W.B. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells. Biochem Pharmacol 1990, 40:2169-2175.
33. Matsumoto N., Manabe H., Ochiai J., Fujita N., Takagi T., Uemura M., et al. An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity. Shock 2003, 19:547-552.
34. Mercanoglu G., Safran N., Gungor M., Pamukcu B., Uzun H., Sezgin C., et al. The effects of nebivolol on apoptosis in a rat infarct model. Circ J 2008, 72:660-670.
35. Napoli C., Sica V., de Nigris F., Pignalosa O., Condorelli M., Ignarro L.J., et al. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 2004, 148:1-5.
36. Oelze M., Daiber A., Brandes R.P., Hortmann M., Wenzel P., Hink U., et al. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertens 2006, 48:677-684.
37. Ohkawa H., Ohishi N., Tagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
38. Ozerol E., Bilgic S., Iraz M., Cigli A., Ilhan A., Akyol O. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:20-24.
39. Ozturk E, Balat O, Acilmis YG, Ozcan C, Pence S, Erel O. Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res 2011;37:337-42.
40. Perret-Guillaume C., Joly L., Jankowski P., Benetos A. Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl 2009, 27:3-7.
41. Rodriguez-Garcia J.L., Botia E., de La Sierra A., Villanueva M.A., Gonzalez-Spinola J. Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke. Am J Hypertens 2005, 18:379-384.
42. Scribner A.W., Loscalzo J., Napoli C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol 2003, 482:95-99.
43. Shi L.L., Chen B.N., Gao M., Zhang H.A., Li Y.J., Wang L., et al. The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats. Life Sci 2011, 88:521-528.
44. Smith M.L., Bendek G., Dahlgren N., Rosen I., Wieloch T., Siesjo B.K. Models for studying long-term recovery following forebrain ischemia in the rat, II: a 2-vessel occlusion model. Acta Neurol Scand 1984, 69:385-401.
45. Soydan G., Cekiç E.G., Tuncer M. Nebivolol has protective effect against endothelial and ileal dysfunction due to I/R. J Surg Res 2011, 166:156-161.
46. Surazynski A., Liu Y., Miltyk W., Phang J.M. Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem 2005, 96:1086-1094.
47. Surazynski A., Donald S.P., Cooper S.K., Whiteside M.A., Salnikow K., Liu Y., et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 2008, 122:1435-1440.
48. Toblli J., Cao G., Rivas C., Munoz M., Giani J., Dominici F., et al. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens 2010, 28:1007-1019.
49. Topsakal C., Kilic N., Erol F.S., Kaplan M., Akdemir I., Tiftikci M., et al. Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury. Acta Neurochir (Wien) 2002, 144:1021-1031.
50. Wang Z.F., Tang L.L., Yan H., Wang Y.J., Tang X.C. Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice. Pharmacol Biochem Behav 2006, 83:603-611.
51. Whaley-Connell A., Habibi J., Johnson M., Tilmon R., Rehmer N., Rehmer J., et al. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat. Am J Nephrol 2009, 30:354-360.
52. Yang J.P., Liu X.F., Liu H.J., Xu G.L., Ma Y.P. Extracellular signal-regulated kinase involved in NGF/VEGF-induced neuroprotective effect. Neurosci Lett 2008, 434:212-217.
53. Yumru M., Savas H.A., Kalenderoglu A., Bulut M., Celik H., Erel O. Oxidative imbalance in bipolar disorder subtypes: a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1070-1074.